Treatment outcomes of small cell carcinoma of the prostate
暂无分享,去创建一个
K. Do | P. Spiess | C. Pettaway | F. Vakar‐Lopez | W. Kassouf | Xuemei Wang | N. Tannir | Rajayogesh Davuluri | J. E. Busby | F. Vakar‐López
[1] R. Millikan,et al. Prostate cancer progression in the presence of undetectable or low serum prostate‐specific antigen level , 2007, Cancer.
[2] M. Oya,et al. Clinicopathological Features Predicting Nodal Metastasis of Testicular Seminoma: Results from 100 Cases in a Single Institute , 2006, Urologia Internationalis.
[3] P. Russo,et al. Renal cell carcinoma recurrence after nephrectomy for localized disease: predicting survival from time of recurrence. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] A. Soran,et al. Are pretreatment serum albumin and cholesterol levels prognostic tools in patients with colorectal carcinoma? , 2006, Medical science monitor : international medical journal of experimental and clinical research.
[5] R. Millikan,et al. 1240: Prospective Evidence Supporting the Utility of Neooadjuvant Chemotherapy in Small Cell Urothelial Cancer: Preliminary Results from A Phase II Clinical Trial at the M.D. Anderson Cancer Center , 2006 .
[6] S. Dahrouge,et al. Genitourinary small cell carcinoma: a retrospective review of treatment and survival patterns at The Ottawa Hospital Regional Cancer Center , 2006, BJU international.
[7] R. Millikan,et al. Evidence supporting preoperative chemotherapy for small cell carcinoma of the bladder: a retrospective review of the M. D. Anderson cancer experience. , 2004, The Journal of urology.
[8] H. Kung,et al. Angiogenesis is not Mediated by Prostate Cancer Neuropeptides , 2004, Angiogenesis.
[9] P. Thall,et al. Results of a phase II study with doxorubicin, etoposide, and cisplatin in patients with fully characterized small-cell carcinoma of the prostate. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] F. Tas,et al. Serum Lactate Dehydrogenase Levels at Presentation Predict Outcome of Patients With Limited‐Stage Small‐Cell Lung Cancer , 2001, American journal of clinical oncology.
[11] A. Psyrri,et al. Small cell lung cancer: strategies to optimize chemotherapy response. , 2001, Cancer journal.
[12] J. Köllermann,et al. Neuroendocrine Differentiation in Prostatic Carcinomas: Histogenesis, Biology, Clinical Relevance, and Future Therapeutical Perspectives , 1999, Urologia Internationalis.
[13] P. Blitzer,et al. Small cell anaplastic carcinoma of the prostate: seven new cases, review of the literature, and discussion of a therapeutic strategy. , 1997, American journal of clinical oncology.
[14] P. Bunn,et al. Overview of chemotherapy for small cell lung cancer. , 1997, Seminars in oncology.
[15] C. Logothetis,et al. Chemotherapy for small cell carcinoma of prostatic origin. , 1992, The Journal of urology.
[16] J. Oesterling,et al. Small cell anaplastic carcinoma of the prostate: a clinical, pathological and immunohistological study of 27 patients. , 1992, The Journal of urology.
[17] F. Johnson,et al. Small cell carcinoma of the prostate , 1991, Cancer.
[18] C. Logothetis,et al. Small cell carcinoma of the prostate part I a clinicopathologic study of 20 cases , 1987, Cancer.
[19] G. Mendelsohn,et al. The histogenesis of small cell carcinoma of the prostate an immunohistochemical study , 1984, Cancer.
[20] A. Pearse,et al. Embryology of the diffuse neuroendocrine system and its relationship to the common peptides. , 1979, Federation proceedings.
[21] R. Wenk,et al. Ectopic ACTH, prostatic oat cell carcinoma, and marked hypernatremia , 1977, Cancer.
[22] D. Evans,et al. Argentaffin cells in prostatic carcinoma: Differentiation from lipofuscin and melanin in prostatic epithelium , 1971, The Journal of pathology.
[23] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .